A pharmacologically acceptable salt of 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound

PK139912AUndetermined Publication Date: 2009-01-03OTSUKA PHARM CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
PK200601225
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-03
Patent Text Reader

Abstract

The present invention provides a 2, 3-dihydro-6-nitroimiciazo [2,1-b] oxazole compound represented by the following general formula: in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, (R)1 and - (CH2) nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, rnulti-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.
Need to check novelty before this filing date? Find Prior Art